Black Currant Oil for Health & Longevity

Created on 11/13/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Unknown – Audit

Black currant oil is a dietary supplement pressed from black currant seeds, not berry skins, supplying plant omega-6 and omega-3 fats for joint, blood pressure, and immune health. Evidence is moderate for rheumatoid pain at high doses, stress blood-pressure spikes, and older-adult immunity, and weak for cholesterol, dry eyes, and hair thinning; no direct human longevity studies exist. Side effects are generally mild; it is no fish-oil omega-3 substitute. (Full Review)

Protocol

Longevity and lipid maintenance
3,000 mg/day oil or 400 mg/day gamma-linolenic acid
Seed oil with 12.6% gamma-linolenic acid in one trial; 400 mg regimen paired with fish oil and sesame lignans in review
Targeted regimens
3,000–10,500 mg/day
Full range in rheumatoid arthritis; 3,600 mg/day elevated blood lipids, 4,500 mg/day older adults (monograph), 6,000 mg/day stress reactivity
Time of day
Oral softgels with breakfast and dinner
Common practice; aligns with mealtime bile and fat-digesting enzyme release to improve fat emulsification and minimize belching
Time to effect
Rheumatoid arthritis joint pain and tenderness
24 weeks
Disease activity signs improved in a 24-week trial without four-measure overall response gains over placebo; systematic review noted effects concentrated at ≥1,400 mg/day gamma-linolenic acid
Stress-induced blood pressure reactivity and diastolic pressure
8 weeks
Blunted stress blood-pressure spikes and resting diastolic pressure at 6,000 mg/day in one trial of borderline-hypertensive men; wider replication has not yet been conducted
T-cell-mediated immune response in older adults
2 months
Increased tetanus skin-test immune response in one trial of healthy adults aged 65 years and older; infection outcomes remain untested

Benefits

Contraindications
  • Individuals with Ribes berry or cross-reactive grass-pollen fruit allergy
  • Patients with active bleeding disorders or surgery within 14 days
  • Individuals with uncontrolled temporal lobe epilepsy
Key Interactions
Theoretical (inferred from mechanism)
  • Prescription anticoagulants and antiplatelets (such as warfarin, clopidogrel)
  • Prescription antihypertensives (such as lisinopril)
  • Phenothiazine antipsychotics (such as chlorpromazine)
  • Over-the-counter nonsteroidal anti-inflammatory drugs and salicylates (such as aspirin, ibuprofen)
  • Antiplatelet, hypotensive, and GLA-containing supplements (fish oil, borage oil, magnesium)
  • Elective surgical and invasive dental procedures

Risk & Side Effects

  • High:
  • Medium:
  • Low: Mild gastrointestinal discomfort and capsule burden; arachidonic acid spillover at high unopposed GLA intakes; cross-reactive oral allergy syndrome; seizure-threshold alteration in drug-refractory psychiatric care
  • Speculative: Antiplatelet effect and perioperative bleeding; liver enzyme elevation on a high-fat, low-fiber diet

Monitoring

Marker Target Why
Plasma or Erythrocyte GLA, DGLA, and AA No established target; tracks increases in GLA and DGLA from individual baseline without rising AA Confirms dihomo-gamma-linolenic acid enrichment and flags arachidonic acid spillover
Fasting Total Cholesterol and LDL-C No established target; tracks reductions from individual fasting baseline Tracks modest long-term total-cholesterol reduction
Seated Resting Blood Pressure No established target; tracks reductions in diastolic pressure and stress-evoked spikes from baseline Checks diastolic buffering and excessive drops with blood-pressure drugs
Serum ALT and AST 7–56 U/L and 8–48 U/L (standard reference range) Flags potential liver strain on a high-fat, low-fiber diet

Cadence: Baseline before starting; seated blood pressure at 4 and 8 weeks; fasting fatty acid, lipid, and liver enzyme panels at 8–12 weeks; follow-up every 6–12 months or 8 weeks after dose changes.

Qualitative Assessment

  • Joint comfort: Morning stiffness duration and grip tenderness logged across 12–24 weeks
  • Ocular and skin comfort: Dry-eye grittiness and seasonal skin dryness tracked over time
  • Tolerability: Stool consistency, post-meal belching, and unusual bruising noted during gradual dose increases